Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux

Matt, U; Selchow, P; Dal Molin, M; Strommer, S; Sharif, O; Schilcher, K; Andreoni, F; Stenzinger, A; Zinkernagel, A S; Zeitlinger, M; Sander, P; Nemeth, J (2017). Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux. International Journal of Antimicrobial Agents, 50(1):55-62.

Additional indexing

Item Type:	Journal Article, refereed, original work
Communities & Collections:	04 Faculty of Medicine > Institute of Medical Microbiology 04 Faculty of Medicine > University Hospital Zurich > Clinic for Infectious Diseases
Dewey Decimal Classification:	610 Medicine & health
Scopus Subject Areas:	Health Sciences > Microbiology (medical) Health Sciences > Infectious Diseases Health Sciences > Pharmacology (medical)
Language:	English
Date:	July 2017
Deposited On:	31 Oct 2017 15:22
Last Modified:	17 Sep 2024 01:36
Publisher:	Elsevier
ISSN:	0924-8579
OA Status:	Closed
Publisher DOI:	https://doi.org/10.1016/j.ijantimicag.2017.02.022
PubMed ID:	28506804
Project Information:	Funder: SNSF Grant ID: 310030_146295 Project Title: Circumvention of Host Innate Immune Defenses by Bacterial Nucleases Funder: SNSF Grant ID: 31003A_153349 Project Title: Tuberculosis - Protein Secretion, modification, Drug and Vaccine Development (TB-PSDVD)